RESVIVAX Trademark

Trademark Overview

On Sunday, April 26, 2020, a trademark application was filed for RESVIVAX with the United States Patent and Trademark Office. The USPTO has given the RESVIVAX trademark a serial number of 88888237. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 16, 2024. This trademark is owned by Novavax, Inc.. The RESVIVAX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Vaccines for human use; vaccine adjuvants for human use

Pharmaceutical, biologic, and vaccine research and development for human use; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants, all for human use; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines, all for human use
resvivax

General Information

Serial Number88888237
Word MarkRESVIVAX
Filing DateSunday, April 26, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 15, 2021

Trademark Statements

Goods and ServicesVaccines for human use; vaccine adjuvants for human use
Goods and ServicesPharmaceutical, biologic, and vaccine research and development for human use; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants, all for human use; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines, all for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 6, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 6, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovavax, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878
Party NameNovavax, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Wednesday, April 29, 2020NEW APPLICATION ENTERED
Wednesday, January 20, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 20, 2020ASSIGNED TO EXAMINER
Monday, July 20, 2020NON-FINAL ACTION WRITTEN
Monday, July 20, 2020NON-FINAL ACTION E-MAILED
Monday, July 20, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 20, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 20, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 10, 2021FINAL REFUSAL E-MAILED
Wednesday, February 10, 2021FINAL REFUSAL WRITTEN
Wednesday, February 10, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, April 6, 2021EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, April 6, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, April 6, 2021EX PARTE APPEAL-INSTITUTED
Tuesday, April 6, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, May 7, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 7, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 7, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 7, 2021EXPARTE APPEAL TERMINATED
Wednesday, May 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 10, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 18, 2022SOU EXTENSION 1 GRANTED
Tuesday, June 15, 2021PUBLISHED FOR OPPOSITION
Tuesday, June 15, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 18, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, January 18, 2022SOU EXTENSION 1 FILED
Thursday, January 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 24, 2022SOU EXTENSION 2 FILED
Thursday, March 24, 2022SOU EXTENSION 2 GRANTED
Thursday, March 24, 2022SOU TEAS EXTENSION RECEIVED
Saturday, March 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 19, 2022SOU TEAS EXTENSION RECEIVED
Monday, December 19, 2022SOU EXTENSION 3 FILED
Monday, December 19, 2022SOU EXTENSION 3 GRANTED
Wednesday, March 29, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 29, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 13, 2023SOU EXTENSION 4 FILED
Wednesday, March 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 13, 2023SOU EXTENSION 4 GRANTED
Saturday, April 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 27, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 27, 2023SOU EXTENSION 5 FILED
Thursday, December 7, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 7, 2023SOU EXTENSION 5 GRANTED
Monday, March 4, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 4, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 16, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 16, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 4, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

resvivax human vaccine research vaccines field adjuvants development pharmaceutical biologic pharmaceuticals